Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1999-09-02
2000-11-07
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
514712, A01N 4112, A61K 31105
Patent
active
061437964
ABSTRACT:
This invention relates to a method of treating patients at risk of developing a free radical induced malignancy. The method includes administering an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification to a patient at risk.
REFERENCES:
Gersl et al., Abstract to "Effects of repeated adminstration of dithiol chelating agent--sodium 2,3-dimercapto-1-propanesulfonate (DMPS)--on biochemical and hematological parameters in rabbits", Acta Med. (Hradex Kralove, Czech Rep.) 40(1), 3-8, 1997.
Sharma et al., Abstract to "Screening of potential chmopreventive agents using biochemical markers of carcinogenesis", Cancer Res. 54(22), 5848-5855, 1994.
BioNumerik Pharmaceuticals, Inc.
Dodd Thomas J.
Jones Dwayne C.
LandOfFree
Method for reducing development of free radical induced malignan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing development of free radical induced malignan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing development of free radical induced malignan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641676